Pseudomonas aeruginosa diversity in distinct paediatric patient groups

Clinical Microbiology and Infection

Volumn 14, Issue 10, 2008, Pages 935-941

  Tramper stranders, G A ^a   can Der Ent, C K ^a   Wolfs, T F W ^a   Kimpen, J L L ^a   Fleer, A ^a   Johansen, U ^b   Johansen, H K ^b   Hoiby N ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chronic suppurative otitis media; Clones; Cystic fibrosis; Diversity; Genotyping; Pseudomonas aeruginosa; Urinary tract infections

Indexed keywords

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CHILD CARE; CHRONIC SUPPURATIVE OTITIS MEDIA; CONTROLLED STUDY; CYSTIC FIBROSIS; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; INTENSIVE CARE; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; URINARY TRACT INFECTION;

PSEUDOMONAS AERUGINOSA;

EID: 52249083518     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02054.x     Document Type: Article

References (35)

1. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 1997; 94: 12088-12093.
2. Mathee K, Ciofu O, Sternberg C et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999; 6: 1349-1357.
3. Boucher JC, Yu H, Mudd MH, Deretic V. Mucoid Pseudomonas aeruginosa in cystic fibrosis: Characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 1997; 65: 3838-3846.
4. Wilson R, Dowling RB. Lung infections. 3. Pseudomonas aeruginosa and other related species. Thorax 1998; 53: 213-219.
5. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005; 171: 1209-1223.
6. O'Carroll MR, Syrmis MW, Wainwright CE et al. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 2004; 24: 101-106.
7. Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 2004; 53: 609-615.
8. Armstrong DS, Nixon GM, Carzino R et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002; 166: 983-987.
9. Wolfgang MC, Jyot J, Goodman AL, Ramphal R, Lory S. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci USA 2004; 101: 6664-6668.
10. Jain M, Ramirez D, Seshadri R et al. Type.III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol 2004; 42: 5229-5237.
11. Wang EW, Jung JY, Pashia ME, Nason R, Scholnick S, Chole RA. Otopathogenic Pseudomonas aeruginosa strains as competent biofilm formers. Arch Otolaryngol Head Neck Surg 2005; 131: 983-989.
12. Ronald A. The etiology of urinary tract infection: Traditional and emerging pathogens. Am J Med 2002; 113 (suppl 1A): 14S-19S.
13. Mizgerd JP, Horwitz BH, Quillen HC, Scott ML, Doerschuk CM. Effects of CD18 deficiency on the emigration of murine neutrophils during pneumonia. J Immunol 1999; 163: 995-999.
14. Nieuwenhuis EE, Matsumoto T, Exley M et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002; 8: 588-593.
15. Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a university hospital, Malatya, Turkey. Am J Infect Control 2006; 34: 188-192.
16. Ben Slama K, Boudabous A, Skande G et al. Heterogeneity among infecting strains of Pseudomonas aeruginosa in diverse departments of a large Tunisian hospital. J Hosp Infect 2001; 47: 325-327.
17. Lomholt JA, Poulsen K, Kilian M. Epidemic population structure of Pseudomonas aeruginosa: Evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun 2001; 69: 6284-6295.
18. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 (suppl 2): S43-S48.
19. Dinesh SD, Grundmann H, Pitt TL, Romling U. European-wide distribution of Pseudomonas aeruginosa clone.C. Clin Microbiol Infect 2003; 9: 1228-1233.
20. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003; 2: 29-34.
21. Romling U, Wingender J, Muller H, Tummler B. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 1994; 60: 1734-1738.
22. Johnson JK, Arduino SM, Stine OC, Johnson JA, Harris AD. Multilocus sequence typing compared to pulsed-field gel electrophoresis for molecular typing of Pseudomonas aeruginosa. J Clin Microbiol 2007; 45: 3707-3712.
23. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
24. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: An application of Simpson's index of diversity. J Clin Microbiol 1988; 26: 2465-2466.
25. Grundmann H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 2001; 39: 4190-4192.
26. Zimakoff J, Hoiby N, Rosendal K, Guilbert JP. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J Hosp Infect 1983; 4: 31-40.
27. Brimicombe RW, Dijkshoorn L, van der Reijden TJ et al. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 2007; 7: 30-36.
28. Jensen ET, Giwercman B, Ojeniyi B et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment. J Hosp Infect 1997; 36: 117-122.
29. Doring G, Jansen S, Noll H et al. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmonol 1996; 21: 90-100.
30. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004; 17: 57-71.
31. Salunkhe P, Smart CH, Morgan JA et al. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 2005; 187: 4908-4920.
32. Macia MD, Blanquer D, Togores B, Sauleda J, Perez JL, Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 2005; 49: 3382-3386.
33. Kenna DT, Doherty CJ, Foweraker J, Macaskill L, Barcus VA, Govan JR. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis. Microbiology 2007; 153: 1852-1859.
34. Giske CG, Libisch B, Colinon C et al. Establishing clonal relationships by multilocus sequence typing between VIM-1-like metallo-[beta]-lactamase-producing Pseudomonas aeruginosa from four European countries. J Clin Microbiol 2006; 44: 4309-4315.
35. Fedler KA, Biedenbach DJ, Jones RN. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: Report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Diagn Microbiol Infect Dis 2006; 56: 427-436.